June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart ...
June 03, 2007
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) ...
May 31, 2007Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the ...
May 30, 2007May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...
May 29, 2007May 29, 2007 — Stentys says the results of preclinical testing of its bifurcated stent were reported at last week's ...
May 28, 2007May 29, 2007 — The FDA has cleared the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System under ...
May 27, 2007May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
May 27, 2007May 29, 2007 — Medtronic Inc. has enrolled the first patient in the landmark PROTECT clinical study, the largest ...
May 27, 2007May 29, 2007 — Boston Scientific Corp. has received CE Mark for its TAXUS Liberte Long paclitaxel-eluting coronary stent ...
May 27, 2007May 23, 2007 — XTENT Inc. announced positive six-month follow-up data from the CUSTOM II clinical trial, which assessed ...
May 21, 2007May 23, 2007 — InspireMD has announced this week the enrollment of 19 patients in its First in Man study in a ...
May 21, 2007May 21, 2007 — OrbusNeich announced today it has received CE Mark approval for three interventional cardiology products ...
May 20, 2007May 18, 2007 — According to a report published Thursday in the Wall Street Journal and posted on UPI, the number of ...
May 17, 2007May 16, 2007 — Stentys has announced that the results of preclinical testing of its bifurcated stent will be reported on ...
May 15, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now